IPSASB unveils the world's first dedicated climate reporting standard for governments and public bodies, mandating disclosures from 2028 to illuminate financial risks and opportunities.
While the S&P 500 is a benchmark for market stability, a closer look reveals diverging fortunes. We analyze one component with strong fundamentals poised for growth and two others where investors should exercise caution.
As economic uncertainty weighs on consumer spending, discretionary stocks have lagged the broader market. We examine three companies—TEGNA, Sabre, and Compass—whose business models and valuations raise significant questions for investors in the current climate.
While rapid growth can inflate valuations, its sustainability separates market leaders from laggards. We analyze one company extending its competitive moat and two others where investors should tread carefully.
While investors chase AI and big tech, a niche biotech firm focused on rare genetic obesity disorders has quietly delivered staggering returns, with Wall Street seeing further 40% upside. Rhythm Pharmaceuticals' targeted approach and upcoming catalysts have analysts bullish, despite its relative anonymity.
Amid a sharp stock decline, ServiceNow's strong Q4 2025 results and a $9.5 billion buyback signal management's confidence. The deeper integration of Anthropic's Claude AI across critical sectors like healthcare and finance is positioned as the central catalyst for its long-term transformation, even as investors question the ROI of massive AI investments.
The world's largest cryptocurrency exchange has initiated the conversion of its user protection fund to Bitcoin, starting with a $100 million on-chain transfer. The move signals a strategic shift towards native crypto assets for safeguarding client funds.
Singapore has officially launched its first national space agency, positioning itself at the forefront of Southeast Asia's push to capitalize on a global space economy projected to surge to $1.8 trillion by 2035.
Under Armour faces a pivotal moment as a significant insider purchase coincides with a high-stakes legal loss and the exit of its Chief Product Officer, testing investor confidence in the embattled sportswear brand's turnaround strategy.
BitMine Immersion Technologies (NYSEAM:BMNR) is navigating a turbulent period marked by over $6 billion in unrealized losses from its concentrated Ethereum holdings and the abrupt departure of its president. The company's aggressive crypto treasury strategy and governance decisions are now under the microscope.
Cogent Biosciences secures FDA Breakthrough Therapy Designation and enters the Real-Time Oncology Review program for its lead drug candidate bezuclastinib in gastrointestinal stromal tumors (GIST), marking significant regulatory momentum for the biotech firm.
As Li Auto's stock languishes near 52-week lows, a deep dive into its valuation metrics suggests the electric vehicle maker may be oversold. With shares trading at a significant discount to intrinsic value estimates, analysts debate whether this is a moment of crisis or a potential buying window.
VEON is deepening its investment in Uzbekistan's digital economy with a new network operations center for Beeline and the launch of BuildX, a software and AI development unit. The moves signal a strategic pivot from traditional telecom services towards higher-margin digital offerings in Central Asia.
Ondas Holdings advances its defense sector ambitions as its Optimus drone gains Blue List status for expedited U.S. procurement, while formally launching its defense and security division at the Singapore Airshow. The strategic moves come as the company's stock, after significant long-term gains, faces recent pressure, testing investor patience for tangible contract wins.
Vice President Sara Duterte faces renewed impeachment efforts in the Philippine Congress, centered on allegations of misusing millions in confidential funds. The move reignites political tensions in a nation grappling with the legacies of powerful political dynasties.
With its stock down 30% over the past year and a fresh 3.5% drop last week, Marvell Technology faces mounting pressure from its powerful institutional base, which controls 81% of the company. Analysts warn that continued underperformance could trigger a wave of selling, impacting all investors.
Digital asset funds have recorded a second consecutive week of massive outflows, totaling $1.7 billion, as hawkish Fed signals and geopolitical tensions trigger a defensive shift. While Bitcoin and Ethereum led the retreat, tokenized precious metals emerged as a rare destination for new capital.
While analyst price targets often paint a rosy picture, a deeper look reveals which recommendations are backed by solid business trends and which may be overly optimistic. We examine one fintech disruptor and one industrial stalwart favored by the Street, alongside a retailer facing significant headwinds.
Profitability alone doesn't guarantee a stock's success. We examine three companies with strong margins, highlighting two that are leveraging their financial health for growth and one where challenges may cloud the future.
While recent market surges have lifted several names, discerning investors must separate fleeting hype from durable growth. We analyze two companies capitalizing on structural shifts and one whose valuation appears dangerously disconnected from fundamentals.
